Catalyst Wire Dossier Catalyst Wire Dossier

FARAPULSE Endocardial Multi Ablation System

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FARAPULSE Endocardial Multi Ablation System, covering 2022-05-04 to 2024-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Feasibility Study of the FARAPULSE Endocardial Multi Ablation System in the Treatment of Persistent Atrial Fibrillation [NA]

See pricing